| Literature DB >> 34532272 |
Juan Zhao1, Li Zhou1, Yan Pan1, Lan Chen1.
Abstract
BACKGROUND: A meta-analysis was conducted to evaluate the curative effect of radical cystectomy in the treatment of muscular invasive bladder cancer (MIBC).Entities:
Keywords: Radical cystectomy; bladder preservation; distant metastasis rate (DMR); muscular invasive bladder cancer (MIBC); survival rate
Year: 2021 PMID: 34532272 PMCID: PMC8421829 DOI: 10.21037/tau-21-564
Source DB: PubMed Journal: Transl Androl Urol ISSN: 2223-4683
Specific meanings of the 4 levels in GRADE
| Level | Definition | Score(s) |
|---|---|---|
| Very low | The estimated effect value was not credible, as it differed greatly from the real value | ≤1 |
| Low | The credibility of the estimated effect value was poor, as it differed greatly from the real value | ≤1 |
| Medium | The credibility of the estimated effect value was sound, as it was close to the real value | 2–5 |
| High | The credibility of the estimated effect value was high, as it was consistent with the real value | ≥6 |
Figure 1Articles retrieval process.
Figure 2The classification results based on the GRADE quality.
Basic information of the included articles
| The first author | Published | Sample size (cases) | Males/females | Research method | Age (years) | Neoplasm staging | Follow–up |
|---|---|---|---|---|---|---|---|
| Williamson SR | 2010 (1) | 70 | 45/25 | Retrospective analysis | 42.4±9.7 | T2–4NχM0 | 1–152 |
| Collins JW | 2014 (2) | 76 | 42/34 | Retrospective analysis | 62.6±9.9 | T2–4N0M0 | 2–64 |
| Aboumarzouk OM | 2012 (3) | 98 | 56/42 | Retrospective analysis | 44.8±8.5 | T2–4N0–1M0 | 3–85 |
| Feifer AH | 2011 (4) | 91 | 51/40 | Retrospective analysis | 59.0±8.6 | T2–4NχM0 | 3–65 |
| Parekh DJ | 2006 (5) | 116 | 62/54 | Retrospective analysis | 47.3±5.8 | T2–4NχM0 | 12–148 |
| McConkey DJ | 2015 (6) | 148 | 85/64 | Retrospective analysis | 28.7±6.5 | T2–4NχM0 | 4–69 |
| Smith ZL | 2013 (7) | 178 | 96/82 | Retrospective analysis | 66.1±7.3 | T2–4N0M0 | 3–164 |
| Dunst J | 2001 (8) | 171 | 103/68 | Retrospective analysis | / | T2–4N0M0 | 4–69 |
| Sherwood BT | 2005 (9) | 150 | 96/54 | Retrospective analysis | 53.3±9.7 | T2–4N0M0 | 3–38 |
| Mmeje CO | 2013 (10) | 184 | 96/88 | Retrospective analysis | 44.3±8.6 | T2–4N0–1M0 | 3–85 |
| Garczyk S | 2020 (11) | 169 | 109/60 | Retrospective analysis | 68.6±10.8 | T2–4N0–1M0 | 1–96 |
| Tränkenschuh W | 2019 (12) | 90 | 52/38 | Retrospective analysis | 42.4±9.7 | T2–4N0–1M0 | 3–162 |
Comparison of survival rates in the included articles
| The first author | Published year | Expt group | Ctrl group | |||
|---|---|---|---|---|---|---|
| Cases | 5-year survival rate (%) | Cases | 5-year survival rate (%) | |||
| Williamson SR | 2010 (1) | 35 | 56.3 | 35 | 52.8 | |
| Collins JW | 2014 (2) | 39 | 54.8 | 37 | 49.6 | |
| Aboumarzouk OM | 2012 (3) | 49 | 49.5 | 49 | 52.8 | |
| Feifer AH | 2011 (4) | 46 | 52.8 | 45 | 63.7 | |
| Parekh DJ | 2006 (5) | 58 | 63.2 | 58 | 46.2 | |
| McConkey DJ | 2015 (6) | 74 | 59.3 | 74 | 45.9 | |
| Smith ZL | 2013 (7) | 89 | 54.8 | 89 | 48.2 | |
| Dunst J | 2001 (8) | 86 | 52.5 | 85 | 53.9 | |
| Sherwood BT | 2005 (9) | 76 | 49.6 | 74 | 56.8 | |
| Mmeje CO | 2013 (10) | 92 | 51.9 | 92 | 63.9 | |
| Garczyk S | 2020 (11) | 86 | 58.2 | 83 | 62.7 | |
| Tränkenschuh W | 2019 (12) | 45 | 46.9 | 45 | 45.5 | |
Figure 3Bar chart for assessment of bias risk of the included articles.
Figure 4Assessment results of the bias risk of the included articles.
Figure 5Funnel chart of the included articles.
Figure 6Forest map for 5-year survival rate under FEM. FEM, fixed-effects model.
Figure 7Forest map for the 5-year survival rate under the random effect model.
Figure 8Forest map for 10-year survival rate.
Figure 9Forest map of the 5-year DMR. DMR, distant metastasis rate.